Emory University at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Emory University takes part in 2 sessions at CTAD 2026 in Boston. Its program centres on proteomics, from plasma signatures in APOE4 homozygotes to the role of proteomics in clinical trials beyond amyloid and tau.

Organization	CTAD 2026 Attendance
Emory University Atlanta, Georgia
emory.edu Universities & institutes Runs an Alzheimer's Disease Research Center and is known for brain and blood proteomics research in Alzheimer's.	Poster Wed Nov 18 7:15am–5:30pm Plasma Proteomics in APOE β4 Homozygotes Identifies a Central Role of the Immune System in Resilience and Susceptibility to Alzheimer’s Disease (P218) Blood and CSF biomarkers · Other mechanisms and targets Talk Thu Nov 19 10:40am–11:05am Beyond Amyloid and Tau: Roles of Proteomics in Clinical Trials Blood and CSF biomarkers · with USC Alzheimer's Therapeutic Research Institute

Organization

CTAD 2026 Attendance

Emory University

Atlanta, Georgia

emory.edu

Universities & institutes

Runs an Alzheimer's Disease Research Center and is known for brain and blood proteomics research in Alzheimer's.

Poster

Wed Nov 18
7:15am–5:30pm

Plasma Proteomics in APOE β4 Homozygotes Identifies a Central Role of the Immune System in Resilience and Susceptibility to Alzheimer’s Disease (P218)

Blood and CSF biomarkers · Other mechanisms and targets

Talk

Thu Nov 19
10:40am–11:05am

Beyond Amyloid and Tau: Roles of Proteomics in Clinical Trials

Blood and CSF biomarkers · with USC Alzheimer's Therapeutic Research Institute

Instantly find 20 buyers from Emory University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction